Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.78
(1.32%)
CNY 13.78
(1.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 183.61 Million CNY | -3.18% |
| 2022 | 189.65 Million CNY | 11.2% |
| 2021 | 170.55 Million CNY | 27.46% |
| 2020 | 133.8 Million CNY | 13.35% |
| 2019 | 118.04 Million CNY | 22.25% |
| 2018 | 96.56 Million CNY | 35.84% |
| 2017 | 71.08 Million CNY | 15.3% |
| 2016 | 61.65 Million CNY | 2.17% |
| 2015 | 60.34 Million CNY | 14.79% |
| 2014 | 52.57 Million CNY | -0.52% |
| 2013 | 52.84 Million CNY | 15.77% |
| 2012 | 45.64 Million CNY | 17.96% |
| 2011 | 38.69 Million CNY | 10.54% |
| 2010 | 35.01 Million CNY | 8.27% |
| 2009 | 32.33 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 174.18 Million CNY | -10.51% |
| 2024 Q1 | 187.06 Million CNY | 1.87% |
| 2024 Q2 | 194.64 Million CNY | 4.05% |
| 2023 Q4 | 183.61 Million CNY | 6.57% |
| 2023 Q1 | 199.61 Million CNY | 5.25% |
| 2023 FY | 183.61 Million CNY | -3.18% |
| 2023 Q3 | 172.3 Million CNY | -8.64% |
| 2023 Q2 | 188.6 Million CNY | -5.51% |
| 2022 Q1 | 191.65 Million CNY | 12.37% |
| 2022 Q4 | 189.65 Million CNY | 0.14% |
| 2022 FY | 189.65 Million CNY | 11.2% |
| 2022 Q3 | 189.38 Million CNY | -5.25% |
| 2022 Q2 | 199.88 Million CNY | 4.3% |
| 2021 Q1 | 163.73 Million CNY | 22.37% |
| 2021 Q3 | 202.96 Million CNY | -0.24% |
| 2021 Q2 | 203.45 Million CNY | 24.26% |
| 2021 Q4 | 170.55 Million CNY | -15.97% |
| 2021 FY | 170.55 Million CNY | 27.46% |
| 2020 Q4 | 133.8 Million CNY | 4.02% |
| 2020 FY | 133.8 Million CNY | 13.35% |
| 2020 Q2 | 134.75 Million CNY | 4.41% |
| 2020 Q3 | 128.64 Million CNY | -4.53% |
| 2020 Q1 | 129.06 Million CNY | 9.33% |
| 2019 Q4 | 118.04 Million CNY | 5.48% |
| 2019 Q1 | 114.39 Million CNY | 18.46% |
| 2019 Q2 | 116.25 Million CNY | 1.63% |
| 2019 Q3 | 111.91 Million CNY | -3.73% |
| 2019 FY | 118.04 Million CNY | 22.25% |
| 2018 Q1 | 72.06 Million CNY | 1.37% |
| 2018 FY | 96.56 Million CNY | 35.84% |
| 2018 Q4 | 96.56 Million CNY | 10.26% |
| 2018 Q3 | 87.58 Million CNY | 13.1% |
| 2018 Q2 | 77.43 Million CNY | 7.46% |
| 2017 Q2 | 74.92 Million CNY | 3.49% |
| 2017 Q3 | 69.2 Million CNY | -7.64% |
| 2017 Q4 | 71.08 Million CNY | 2.73% |
| 2017 FY | 71.08 Million CNY | 15.3% |
| 2017 Q1 | 72.39 Million CNY | 17.42% |
| 2016 Q2 | 61.45 Million CNY | 0.59% |
| 2016 Q1 | 61.09 Million CNY | 1.23% |
| 2016 Q4 | 61.65 Million CNY | 4.72% |
| 2016 Q3 | 58.87 Million CNY | -4.19% |
| 2016 FY | 61.65 Million CNY | 2.17% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q4 | 60.34 Million CNY | 3.41% |
| 2015 Q3 | 58.35 Million CNY | -4.85% |
| 2015 Q2 | 61.33 Million CNY | 0.0% |
| 2015 FY | 60.34 Million CNY | 14.79% |
| 2014 Q4 | 52.57 Million CNY | 0.0% |
| 2014 FY | 52.57 Million CNY | -0.52% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 52.84 Million CNY | 15.77% |
| 2012 FY | 45.64 Million CNY | 17.96% |
| 2011 FY | 38.69 Million CNY | 10.54% |
| 2010 FY | 35.01 Million CNY | 8.27% |
| 2009 FY | 32.33 Million CNY | 0.0% |